boston scally company, LLC

80 state st.
albany, new york 12207

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 17, 2014

NYS DOS ID#
4545101

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
CORPORATION SERVICE COMPANY
80 STATE ST.
ALBANY, NEW YORK, 12207

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - BOSTON SCALLY COMPANY, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • NY AG presses TransUnion, Experian for cybersecurity details
    By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017

    ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.

    Source: SFGATE.com: Tech News
  • AquaBounty Lines Up First U.S. Fish Farm With Deal for Indiana Site
    By Frank Vinluan - Tuesday Jun 13, 2017

    When salmon from AquaBounty Technologies reach grocery stores and restaurants, some of them will come from America’s heartland. AquaBounty (NASDAQ: AQB) has agreed to pay $14 million in cash to acquire some of the assets of Bell Fish Company, including that company’s fish farm in Albany, IN. The deal will give Maynard, MA-based AquaBounty its […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy New York
boston scally company llc albany ny